Stem cells differentiated into brain and neural organoids may help scientists understand both brain development and ...

From new payload linkers to artificial intelligence partnerships, advances in ADC pipelines push forward selective cancer therapies that minimize side effects.

Regions face reduced federal research funding and shrinking venture capital for startups, though rankings stay consistent.

Circular RNA may be part of the solution. Because circular RNA has no ends to degrade—unlike linear RNA—the molecule is more stable and its half-life is extended.

Novel allogeneic stem cells and differentiated iPSCs are providing more physiologically relevant disease models.

The breakome is a new layer in the multiomics landscape—alongside the genome, transcriptome, proteome, and interactome. While it hasn’t traditionally been included among these other omics, we consider ...

Novel sponge developed by Takara Bio USA enables effective preparation of T cells for CAR T-cell therapy research from primary PBMC samples.

These soluble protein agonists can replicate Notch activation in suspension culture, opening the door to scalable T-cell therapies.

The study links aging organisms' inability to sustain production of key proteins to impaired translation and increased ...

Researchers used ShortStop to Identify a microprotein that potentially represents a biomarker or functional microprotein for lung cancer.

Blocking a key metabolic enzyme helps B cells fight liver tumors, revealing a new immunotherapy pathway for fatty liver–driven cancer in mice.

The remainder of 2025 will be busy for Vir Biotechnology as it strives to successfully pivot to developing cancer and infectious disease therapies.